Differential expression of SDF-1 receptor CXCR4 in molecularly defined forms of inherited thrombocytopenias

Platelets

Volumn 28, Issue 6, 2017, Pages 602-606

  Salim, Juan P ^a   Glembotsky, Ana C ^a   Lev, Paola R ^a   Marin Oyarzún, Cecilia P ^a   Goette, Nora P ^a   Molinas, Felisa C ^a   Marta, Rosana F ^a   Heller, Paula G ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

CXCR4; inherited thrombocytopenias; SDF 1

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MESSENGER RNA; RNA; ANKRD26 PROTEIN, HUMAN; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; NUCLEAR PROTEIN; STROMAL CELL DERIVED FACTOR 1;

ACUTE LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BERNARD SOULIER DISEASE; BIOGENESIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FLOW CYTOMETRY; FOLLOW UP; GENE EXPRESSION; GRAY PLATELET SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; INHERITED THROMBOCYTOPENIA; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE MEMBRANE; THROMBOCYTOPENIA; BIOSYNTHESIS; BLOOD; FEMALE; GENE EXPRESSION REGULATION; GENETIC DISORDER; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; THROMBOCYTE;

ADOLESCENT; ADULT; AGED; BLOOD PLATELETS; CHEMOKINE CXCL12; CHILD; FEMALE; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; HUMANS; MALE; MEGAKARYOCYTES; MIDDLE AGED; NUCLEAR PROTEINS; PLATELET AGGREGATION; RECEPTORS, CXCR4; THROMBOCYTOPENIA;

EID: 85007478155     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537104.2016.1254763     Document Type: Article

References (18)

1. Hamada T, Möhle, R, Hesselgesser J, Hoxie J, Nachman RL, Moore MA, Rafii S., Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med 1998;188:539–548.
2. Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, Jin DK, Dias S, Zhang F, Hartman TE, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004;10:64–71.
3. Niswander LM, Fegan KH, Kingsley PD, Mc Grath KE, Palis J. SDF-1, dynamically mediates megakaryocyte niche occupancy and thrombopoiesis at steady state and following radiation injury. Blood 2014;124:277–286.
4. Massberg S, Konrad I, Schürzinger K, Lorenz M, Schneider S, Zohlnhoefer D, Hoppe K, Schiemann M, Kennerknecht E, Sauer S, et al. Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivo. J Exp Med 2006;203:1221–1233.
5. Walsh TG, Harper MT, Poole AW. SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4. Cell Signal 2015;27:37–46.
6. Salim JP, Goette NP, Lev PR, Chazarreta CD, Heller PG, Alvarez C, Molinas FC, Marta RF., Dysregulation of SDF-1/CXCR4 axis in the megakaryocytic lineage in Essential Thrombocythemia. Br J Haematol 2009;144:69–77.
7. Balduini CL, Melazzini F, Pecci A., Inherited thrombocytopenias-recent advances in clinical and molecular aspects. Platelets 2016 May 9:1–11. DOI:10.3109/09537104.2016.1171835.
8. Lentaigne C, Freson K, Laffan MA, Turro E, Ouwehand WH,; BRIDGE-BPD consortium and the thrombogenomics consortium. Inherited platelet disorders: toward DNA-based diagnosis. Blood 2016;127:2814–2823.
9. Heller PG, Glembotsky AC, Goette NP, Marta RF, Lev PR, Molinas FC., Diverse Mpl expression pattern among pedigrees with inherited thrombocytopenia: potential diagnostic and therapeutic implications. J Thromb Haemost 2008;6:2215–2217.
10. Glembotsky AC, Marta RF, Pecci A, De Rocco D, Gnan C, Espasandin YR, Goette NP, Negro F, Noris P, Savoia A, et al. International collaboration as a tool for diagnosis of patients with inherited thrombocytopenia in the setting of a developing country. J Thromb Haemost 2012;10:1653–1661.
11. Glembotsky AC, Bluteau D, Espasandin YR, Goette NP, Marta RF, Marin Oyarzun CP, Korin L, Lev PR, Laguens R, Molinas FC, et al. Mechanisms underlying platelet function defect in a pedigree with FPD/AML: potential role for candidate RUNX1-targets. J Thromb Haemost 2014;12:761–772.
12. Noris P, Perrotta S, Seri M, Pecci A, Gnan C, Loffredo G, Pujol-Moix N, Zecca M, Scognamiglio F, De Rocco D, et al. Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: analysis of 78 patients from 21 families. Blood 2011;117:6673–6680.
13. Nurden AT, Nurden P., The gray platelet syndrome: clinical spectrum of the disease. Blood Rev. 2007;21:21–36.
14. Larocca LM, Heller PG, Podda G, Pujol-Moix N, Glembotsky AC, Pecci A, Alberelli MA, Balduini CL, Landolfi R, Cattaneo M, et al. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome. Platelets 2015;26:751–757.
15. Wang JD, Ou TT, Wang CJ, Chang TK, Lee HJ., Platelet apoptosis resistance and increased CXCR4 expression in pediatric immune thrombocytopenic purpura. Thromb Res 2010;126:311–318.
16. Bluteau D, Balduini A, Balayn N, Currao M, Nurden P, Deswarte C, Leverger G, Noris P, Perrotta S, Solary E, et al. Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation. J Clin Invest 2014;124:580–591.
17. Marchese A., Endocytic trafficking of chemokine receptors. Curr Opin Cell Biol 2014;27:72–77.
18. Chatterjee M, Seizer P, Borst O, Schönberger T, Mack A, Geisler T, Langer HF, May AE, Vogel S, Lang F, Gawaz M., SDF-1α induces differential trafficking of CXCR4-CXCR7 involving cyclophilin A, CXCR7 ubiquitination and promotes platelet survival. FASEB J 2014;28:2864–2878.